Detalhe da pesquisa
1.
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia.
Hematol Oncol
; 41(3): 520-534, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383121